Comparable survival in rats with intracranial glioblastoma irradiated with single-fraction conventional radiotherapy or FLASH radiotherapy
BackgroundRadiotherapy increases survival in patients with glioblastoma. However, the prescribed dose is limited by unwanted side effects on normal tissue. Previous experimental studies have shown that FLASH radiotherapy (FLASH-RT) can reduce these side effects. Still, it is important to establish a...
Main Authors: | Emma Liljedahl, Elise Konradsson, Karin Linderfalk, Emma Gustafsson, Kristoffer Petersson, Crister Ceberg, Henrietta Nittby Redebrandt |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2024-01-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2023.1309174/full |
Similar Items
-
Combined anti-C1-INH and radiotherapy against glioblastoma
by: Emma Liljedahl, et al.
Published: (2023-01-01) -
Long-term anti-tumor effects following both conventional radiotherapy and FLASH in fully immunocompetent animals with glioblastoma
by: Emma Liljedahl, et al.
Published: (2022-07-01) -
Increased effect of two-fraction radiotherapy in conjunction with IDO1 inhibition in experimental glioblastoma.
by: Jonatan Ahlstedt, et al.
Published: (2020-01-01) -
Beam control system and output fine-tuning for safe and precise delivery of FLASH radiotherapy at a clinical linear accelerator
by: Elise Konradsson, et al.
Published: (2024-01-01) -
What is the role of CRP in glioblastoma?
by: Karolina Förnvik, et al.
Published: (2021-01-01)